TCL Archive Also in this 8-page issue: House Committee on Energy and Commerce is investigating the collapse of the Institute for Cancer Prevention, which owes $5.7 million to NCI. December 3, 2004
TCL Archive Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival August 31, 2012
TCL Archive NCI Grant Funding Up $74 Million; Centers, Groups also Receive Funding Boost March 8, 1996
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
